News
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
12 Apr 24
Trading Ideas
Beyond The Numbers: 6 Analysts Discuss Catalent Stock
4 Apr 24
Analyst Ratings
Stephens & Co. Reiterates Equal-Weight on Catalent, Maintains $63.5 Price Target
4 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Invenra To Collaborate With Catalent To Co-Discover Novel Bispecific ADCs
2 Apr 24
News, Contracts
Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug
8 Mar 24
Biotech, Large Cap, News, Health Care, Markets, Movers, Trading Ideas, General
Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk
6 Mar 24
Biotech, Large Cap, News, Health Care, General
Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla
1 Mar 24
Equities, Large Cap, Broad U.S. Equity ETFs, Top Stories, Markets, Tech, ETFs
Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)
29 Feb 24
Biotech, Equities, Large Cap, Mid Cap, Social Media, Broad U.S. Equity ETFs, Health Care, Price Target, Small Cap, Top Stories, Analyst Ratings, Tech, ETFs, General
(CTLT) - Analyzing Catalent's Short Interest
28 Feb 24
Short Sellers, Short Ideas, Trading Ideas
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
26 Feb 24
Earnings, Equities, Large Cap, News, Sector ETFs, Health Care, Price Target, Markets, ETFs, General
In-Depth Examination Of 5 Analyst Recommendations For Catalent
20 Feb 24
Analyst Ratings
RBC Capital Reiterates Sector Perform on Catalent, Maintains $63.5 Price Target
20 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest?
14 Feb 24
Equities, Large Cap, Mid Cap, Short Sellers, Technicals, Top Stories, Trading Ideas
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs
12 Feb 24
Biotech, Large Cap, News, Health Care, General
Catalent Q2 Adjusted EPS $(0.24) May Not Be Comparable To $(0.02) Estimate, Sales $1.03B Beat $1.01B Estimate
9 Feb 24
Earnings, News
US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March
9 Feb 24
Earnings, Equities, News, Futures, Previews, Top Stories, Economics, Federal Reserve, Pre-Market Outlook, Markets, Movers, Trading Ideas
Earnings Scheduled For February 9, 2024
9 Feb 24
Earnings
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
8 Feb 24
Analyst Color, Biotech, Health Care, Econ #s, Top Stories
Earnings Outlook For Catalent
8 Feb 24
Earnings
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns
7 Feb 24
News, Health Care, FDA, General
Press releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FFNW, MGRC, CTLT, HRT
23 Apr 24
Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, CHRD
20 Apr 24
Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SCX
18 Apr 24
Press Releases
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)
17 Apr 24
Press Releases
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX
17 Apr 24
Penny Stocks, Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA
11 Apr 24
Press Releases
Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
10 Apr 24
News, Legal, Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, SCX, EVBG, NS
4 Apr 24
News, Legal, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI
22 Mar 24
Press Releases
Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm
22 Mar 24
News, Legal, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, ZFOX
12 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
11 Mar 24
Press Releases
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, FREE, KNTE
9 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
7 Mar 24
News, Legal, Press Releases
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
7 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, KAMN, AVRO
2 Mar 24
Press Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Catalent, Inc. by Novo Holdings
1 Mar 24
News, Legal, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, FREE, NGM
28 Feb 24
News, Legal, Press Releases
Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm
27 Feb 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KAMN, CTLT, BATL
27 Feb 24
Press Releases